This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Epilobium parviflorum
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
A European willowherb specifically used for prostate health and BPH by Maria Treben.
A European willowherb specifically used for prostate health and BPH by Maria Treben. Key active compounds include oenothein A, oenothein B, ellagitannins.
oenothein A, along with oenothein B and ellagitannins, are the primary bioactive compounds in Epilobium parviflorum. These compounds modulates NF-κB and COX-2 inflammatory pathways.
BPH management
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Prostate health
Prostate conditions
Based on traditional use; clinical evidence limited
BPH treatment
Based on traditional use; clinical evidence limited
Urinary conditions
Based on traditional use; clinical evidence limited
Found an error or have a correction for Epilobium parviflorum?
Report an Issue →